Early Type 1 Diabetes Screening in Children: What Families Should Know
Plain-language guide to early type 1 diabetes screening in children, autoantibodies, risk, follow-up, teplizumab context...
Diabetes Apps in 2026: How to Choose Safer Tools
Diabetes apps can track glucose, food, medicines, and reports. Learn how to choose safer tools...
Dexcom G7 Sensor Recall: Lot Numbers, Risks, and What to Do
Dexcom G7 sensor recall guide covering affected lots, stolen scrapped products, infection and no-reading risks...
CGM and Type 1 Diabetes Complications: What Adults Should Know
A nationwide Korean cohort study linked continuous glucose monitoring with lower rates of several serious...
Canagliflozin 100 mg vs 300 mg: What a New Kidney and Heart Outcomes Analysis Found
A post hoc CANVAS analysis found no clear kidney or cardiovascular advantage for canagliflozin 300...
Cagrilintide-semaglutide plus basal insulin lowered A1C and weight in adults with type 2 diabetes
A Lancet phase 3a trial found cagrilintide-semaglutide added to basal insulin lowered A1C and weight...
Berobenatide VESPER Results: What Patients Should Know
Phase 2b VESPER data suggest berobenatide may lower weight and A1C, but it remains investigational...
Awiqli Once-Weekly Basal Insulin: What Adults With Type 2 Diabetes Should Know
Awiqli is FDA-approved as a once-weekly basal insulin for adults with type 2 diabetes. Learn...
Automated Insulin Delivery and Advanced Kidney Disease: What People With Diabetes Should Know
A randomized trial found that automated insulin delivery improved time in range for adults with...